financial guidance
Abbott Q4 Diagnostics Revenues Fall 26 Percent on Declining COVID-19 Sales
The company announced that its total revenues for the quarter declined 12 percent, while revenues for the full year rose 1 percent.
Danaher Q4 Revenues Rise 3 Percent Despite Difficulties in China
The firm's Life Sciences segment saw 8 percent growth year over year, while the Diagnostics sector rose 3 percent in the quarter.
Sema4 Changes Name to GeneDx, Provides Preliminary 2022 Revenues, 2023 Guidance
As it exits reproductive health screening this quarter, the newly renamed GeneDx expects 2022 revenues of $170 million to $173 million and 2023 revenues of $205 million to $220 million in pursuit of profitability by 2025.
Agilent Fiscal Q4 Revenues Rise 11 Percent, Full-Year 2022 Revenues Grow 8 Percent
The firm's Life Sciences and Applied Markets group's revenues were up 16 percent, and the Diagnostics and Genomics group's revenues grew 3 percent.
SomaLogic Scores One-Time, $21.2M Licensing Royalty in Q3, Raises FY 2022 Revenue Guidance
The Boulder, Colorado-based proteomics assay maker beat Wall Street estimates on the top and bottom lines in Q3, driven by higher product revenues.